Stock Report

All about this stock under one free report Last Updated: 06-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Bajaj Healthcare Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: BAJAJHCARE | BSE: 539872

₹321.45

up-down-arrow ₹-3.75 (-1.15%)

As on 04-Sep-2026 15:53IST

Market cap

info icon

₹1,082 Cr

Revenue (TTM)

info icon

₹628 Cr

P/E Ratio

info icon

47

P/B Ratio

info icon

2

Div. Yield

info icon

0.5 %

Edit peer-selector-edit
Bajaj Healthcare Emcure Pharmaceuticals Neuland Lab Alivus Life Sciences Sudeep Pharma
Market cap (₹ Cr)
 1,082 36,584 29,051 16,782 15,009
Revenue (₹ Cr)
 628 9,683 2,372 2,590 676
Net Profit (₹ Cr)
 17.63 1,018.97 497.77 603.02 183.60
Net Margin (%)
 3.63 10.47 20.72 22.63 26.06
RoE (%)
 11.68 21.30 28.49 19.61 22.72
Price to Earnings
 47.00 36.17 58.36 27.83 82.18
Price-To-Book
 1.98 6.99 14.37 4.82 16.25

Income Statement (₹ Cr)

Bajaj Healthcare Emcure Pharmaceuticals Neuland Lab Alivus Life Sciences Sudeep Pharma
Operating Revenue arrow
627.83 9,683.45 2,371.81 2,590.40 675.61
Total Income arrow
634.90 9,730.84 2,402.61 2,664.23 704.48
Total Expenditure arrow
518.77 7,739.53 1,608.91 1,753.71 442.67
EBITDA arrow
109.06 1,943.92 762.90 836.69 232.94
Depreciation arrow
28.93 425.10 98.11 78.88 15.56
EBIT arrow
80.13 1,518.82 664.79 757.81 217.38
Interest arrow
23.10 148.45 26.33 5.43 7.96
Other Income arrow
7.07 47.39 30.80 73.83 28.87
Exceptional Items arrow
-33.25 -27.85 0.00 -25.66 0.00
Profit before Tax arrow
30.85 1,389.91 669.26 800.55 238.30
Provision for Tax arrow
7.83 370.94 171.48 197.53 54.69
Profit after Tax arrow
23.03 1,018.97 497.77 603.02 183.60

Liabilities (₹ Cr)

Bajaj Healthcare Emcure Pharmaceuticals Neuland Lab Alivus Life Sciences Sudeep Pharma
Shareholder's Funds arrow
533.00 4,950.03 1,874.47 3,332.13 883.34
Minority Interest arrow
0.00 -7.58 0.00 0.00 -0.97
Non-Current Liabilities arrow
70.65 723.57 345.47 142.73 74.82
Current Liabilities arrow
319.56 3,912.24 710.20 508.04 201.96
Total Liabilities arrow
833.05 8,121.73 2,179.88 3,753.59 716.85

Assets (₹ Cr)

Bajaj Healthcare Emcure Pharmaceuticals Neuland Lab Alivus Life Sciences Sudeep Pharma
Non-Current Assets arrow
237.13 3,392.16 1,290.62 1,321.38 477.92
Current Assets arrow
569.08 5,612.10 1,483.13 2,649.36 623.97
Total Assets arrow
833.05 8,121.73 2,179.88 3,753.59 716.85
Total Debt* arrow
222.62 731.70 136.01 0.00 135.25
Net Current Assets arrow
249.52 1,699.86 772.93 2,141.33 422.01
Contingent Liabilities arrow
60.53 393.94 8.97 4.82 0.10

Cashflow (₹ Cr)

Bajaj Healthcare Emcure Pharmaceuticals Neuland Lab Alivus Life Sciences Sudeep Pharma
Cash From Operating Activities arrow
21.62 851.71 317.40 391.52 48.73
Cash Flow from Investing Activities arrow
-14.82 -94.00 -298.16 -615.65 -78.76
Cash from Financing Activities arrow
-6.38 -813.96 24.96 -6.23 52.70
Net Cash Inflow / Outflow arrow
0.43 -56.25 44.21 -230.35 22.67

Ratios

Profitability Ratios

 Bajaj Healthcare Emcure Pharmaceuticals Neuland Lab Alivus Life Sciences Sudeep Pharma
ROCE (%) arrow
11.40 22.49 23.45 25.50 35.83
ROE (%) arrow
11.68 21.30 28.49 19.61 22.72
ROA (%) arrow
2.62 11.42 19.48 16.31 31.25
EBIT Margin (%) arrow
12.76 15.68 28.03 29.25 32.18
Net Margin (%) arrow
3.63 10.47 20.72 22.63 26.06
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Bajaj Healthcare Emcure Pharmaceuticals Neuland Lab Alivus Life Sciences Sudeep Pharma
Revenue Growth (%) arrow
12.27 18.36 78.33 7.93 23.56
EBIT Growth (%) arrow
44.11 30.43 303.07 19.88 12.00
Net Profit Growth (%) arrow
-51.09 32.39 182.61 21.66 20.07
EPS Growth (%) arrow
22.40 36.68 277.72 25.42 50.65
Book Value Growth (%) arrow
61.16 50.94 18.89 20.94 37.86

Valuation Ratios

 Bajaj Healthcare Emcure Pharmaceuticals Neuland Lab Alivus Life Sciences Sudeep Pharma
Price / Earnings arrow
17.62 35.43 58.36 26.95 78.98
Price / Book Value arrow
1.98 6.99 14.37 4.82 16.25
Dividend Yield (%) arrow
0.47 0.19 0.15 0.37 0.11
EV/EBITDA arrow
11.92 19.36 37.87 19.12 64.58
Market Cap (₹ Cr) arrow
2,121.47 20,327.45 15,494.53 13,228.83 0.00

Solvency Ratios

 Bajaj Healthcare Emcure Pharmaceuticals Neuland Lab Alivus Life Sciences Sudeep Pharma
Debt to Equity arrow
0.09 0.05 0.09 0.00 0.04
Short term debt to equity ratio arrow
0.29 0.11 -- -- 0.17
Current Ratio arrow
1.78 1.43 2.09 5.21 3.09
Quick Ratio arrow
1.10 0.82 1.37 3.85 2.02
Interest Coverage arrow
2.34 10.36 26.41 148.49 30.94

Operating Efficiency Ratios

 Bajaj Healthcare Emcure Pharmaceuticals Neuland Lab Alivus Life Sciences Sudeep Pharma
Debtors to sales (%) arrow
37.25 26.46 22.82 41.42 33.68
Asset Turnover arrow
0.71 1.09 0.93 0.70 1.15
Receivable days arrow
145.27 87.83 85.17 132.12 114.95
Inventory Days arrow
102.90 78.64 90.97 102.08 68.03
Payable days arrow
117.80 174.97 137.94 133.54 133.44
Cash Conversion Cycle arrow
130.36 -8.50 38.21 100.66 49.53
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...